MICHAEL VOLK to Risk Factors
This is a "connection" page, showing publications MICHAEL VOLK has written about Risk Factors.
Connection Strength
0.197
-
Strategies to Reduce 30-Day Readmissions in Patients with Cirrhosis. Curr Gastroenterol Rep. 2017 Jan; 19(1):1.
Score: 0.051
-
Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation. Gastroenterology. 2008 Nov; 135(5):1568-74.
Score: 0.029
-
Liver transplantation for hepatocellular carcinoma: who benefits and who is harmed? Gastroenterology. 2008 May; 134(5):1612-4.
Score: 0.028
-
Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study. Hepatology. 2022 06; 75(6):1471-1479.
Score: 0.018
-
Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates. Hepatology. 2021 03; 73(3):1132-1139.
Score: 0.017
-
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma. Gastroenterology. 2019 11; 157(5):1253-1263.e2.
Score: 0.015
-
Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver?Transplantation. Gastroenterology. 2019 Apr; 156(5):1381-1391.e3.
Score: 0.015
-
Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List. Gastroenterology. 2017 10; 153(4):988-995.
Score: 0.013
-
Clinical yield of diagnostic endoscopic retrograde cholangiopancreatography in orthotopic liver transplant recipients with suspected biliary complications. Liver Transpl. 2012 Dec; 18(12):1479-84.
Score: 0.010